Dr. P N Mohapatra – Top Medical Oncologist in India

About Dr. PN Mohapatra

Dr. P N Mohapatra is an expert in systemic cancer therapies, he specialises in administering Chemotherapy (including intravenous, oral, and metronomic regimens), Targeted Therapy, Immunotherapy, Hormone Therapy, and cutting-edge CAR T-Cell Therapy. His clinical focus encompasses a wide range of malignancies, particularly Breast; he Cancer, Lung Cancer, Gastrointestinal Malignancies, Lymphomas, and Leukaemias. Dr. Mohapatra plays a crucial role in advancing cancer treatment through his extensive involvement as a Principal Investigator in numerous international and national clinical trials (Phase III & IV). His commitment extends to holistic patient care, evidenced by his membership in the Indian Association of Palliative Care and major international oncology societies like ASCO and ESMO. Fluent in English, Hindi, and Bengali, he ensures comprehensive and compassionate communication with his patients.

OPD Schedule Of Dr. PN Mohapatra

Consultation Fees Rs. /-

Apollo Gleneagles Hospital, Kolkata

MON 09:00 AM - 06:00 PM

TUE 09:00 AM - 06:00 PM

WED 09:00 AM - 06:00 PM

THU 09:00 AM - 06:00 PM

FRI 09:00 AM - 06:00 PM

SAT 09:00 AM - 06:00 PM

Medical Degrees

MBBS (1990)
MD (General Medicine) (1995)
DM (Medical Oncology) (2005)

Certifications & Accreditations

ECMO (European Certification in Medical Oncology – ESMO)
OMC Registration (Orissa Medical Council)

Major Cancer Types Treated

Breast Cancer
Lung Cancer (including Small Cell & Non-Small Cell)
Gastrointestinal Malignancies (Stomach, Colorectal, Esophageal, Pancreatic, Liver, Bile Duct – Cholangiocarcinoma)
Lymphomas (Hodgkin’s & Non-Hodgkin’s)
Leukaemias (ALL, Hairy Cell Leukemia)
Genitourinary Cancers (Renal Cell Carcinoma, Prostate Cancer – implied by trials)
Head & Neck Cancers/Oral Cancer
Gynaecological Cancers (Ovarian)
Skin Cancers (Melanoma, Actinic Keratosis)
Sarcomas/Histiocytosis
Wide range of other Solid Tumours

Sub-specialties

Medical Oncology
Clinical Haematology
Palliative Care

Advanced Procedures Performed

Chemotherapy (Intravenous, Oral, Metronomic)
Targeted Therapy
Immunotherapy
Hormone Therapy
CAR T-Cell Therapy

Current & Past Hospital AffiliationsDirector – Medical Oncology: Apollo Cancer Centre / Apollo Multispecialty Hospitals, Kolkata (Current)Academic & Research Roles

Principal Investigator: Multiple international and national clinical trials (Phase III and Phase IV).
Member: Indian Association of Palliative Care (IAPC)
Member: American Society of Clinical Oncology (ASCO)
Member: European Society for Medical Oncology (ESMO)

Published Papers in Medical Journals (Selected Examples)

“Efficacy and safety of nanosomal docetaxel lipid suspension in Indian patients with metastatic castration-resistant prostate cancer (mCRPC): A multicenter, open-label, single-arm phase 4 study.” Journal of Clinical Oncology (Expected Feb 2025 – Abstract).
“Landscape of metastatic colorectal cancer (CRC) using comprehensive circulating tumor DNA (ctDNA) next-generation sequencing (NGS) in India: Expanding beyond RAS and RAF.” Journal of Clinical Oncology (Expected Feb 2025 – Abstract).
“Safety of Abemaciclib in Indian Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced and/or Metastatic Breast Cancer: A Multicenter, Nonrandomized, Open-Label, Single-Arm, Phase 4 Study.” South Asian Journal of Cancer (Jan 2025).
“Optimizing Premenopausal Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer Management in India: Insights From Expert Consensus.” Cureus (Dec 2024 – Literature Review/Consensus).
“Current Practices in Genetic Testing for Prostate Cancer: The Indian Scenario.” Indian Journal of Public Health (Sep 2024).
“Practical Clinical Consensus Guidelines for the Management of Cancer Associated Anemia (CAA) in Low- and Middle-Income Countries (LMIC).” South Asian Journal of Cancer (Sep 2023).
“ExPert ConsEnsus on the management of Advanced clear-cell RenaL celL carcinoma: INDIAn Perspective (PEARL-INDIA).” BMC Cancer (Aug 2023).

Ongoing Clinical Trials Participation

Actively serves as Principal Investigator for multiple ongoing international and national clinical trials (Phase III & IV).

Cancer treatment costs vary significantly based on the specific drugs used (Chemo, Targeted, Immuno, CAR-T), duration of therapy, cycles required, and supportive care needs. Below are very broad estimates.

Treatment Type	Estimated Cost (INR)	Estimated Cost (USD)
Chemotherapy	₹ 30,000 – ₹ 1,50,000+	$ 360 – $ 1,800+
Targeted Therapy	₹ 1,00,000 – ₹ 5,00,000+	$ 1,200 – $ 6,000+
Immunotherapy	₹ 1,50,000 – ₹ 4,00,000+	$ 1,800 – $ 4,800+
Hormone Therapy	₹ 5,000 – ₹ 50,000+	$ 60 – $ 600+

Disclaimer: These are rough estimates. Actual costs depend heavily on specific drugs, protocols, and patient factors. Contact Cancer Rounds for details.

Language Support: Dr. Mohapatra is fluent in English, Hindi, and Bengali. Cancer Rounds and Apollo Hospitals’ international patient services can arrange for interpreters for other languages.
Visa & Travel Assistance: Support with medical visa applications, travel arrangements, airport transfers, and accommodation booking is available through Apollo Hospitals and the Cancer Rounds team.
Pre-treatment Virtual Consultations: Dr. Mohapatra offers online consultations (Fee: ₹1000). International patients can use this service via the hospital’s platform or Cancer Rounds for initial discussions, second opinions, and preliminary planning.

“Dr. Mohapatra’s expertise in targeted therapy for my lung cancer was exceptional. He explained the treatment plan clearly and managed the side effects proactively. His experience as a clinical trial investigator gave me immense confidence.” – Mr. A. Ghosh. “Being diagnosed with lymphoma was overwhelming, but Dr. P N Mohapatra guided me through chemotherapy and immunotherapy with great care and professionalism. His calm demeanour and fluency in Bengali were very helpful.” – Mrs. S. Roy. “As Director, Dr. Mohapatra leads an excellent team. My treatment for advanced GI cancer involved complex immunotherapy, and his deep knowledge and patient-focused approach made a significant difference in my journey.” – Mr. R. Banerjee.

Patient-Centred Care: Dr. Mohapatra prioritises patient well-being, combining his vast clinical experience with a compassionate approach. His fluency in multiple languages (English, Hindi, Bengali) facilitates clear communication, and his membership in the Indian Association of Palliative Care underscores his commitment to holistic support throughout the treatment process.
Technology & Innovation: As a leader in the field and Principal Investigator in numerous trials, Dr. Mohapatra stays at the forefront of oncological advancements. He expertly utilises the latest systemic therapies, including Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, and pioneering treatments like CAR T-Cell Therapy, tailoring them to individual patient needs based on evidence-based medicine.

Frequently Asked Questions

Dr. P N Mohapatra is a highly experienced Medical Oncologist, specializing in the treatment of cancer using systemic therapies like chemotherapy, targeted therapy, immunotherapy, and CAR T-Cell therapy.

Dr. P N Mohapatra, Best Oncologist in Kolkata, has over 35 years of extensive experience in the field of Medical Oncology.

Dr. P N Mohapatra, Cancer Specialist in Kolkata treats a wide range of solid tumours and haematological malignancies, with special expertise in Breast Cancer, Lung Cancer, Gastrointestinal Cancers, Lymphomas, and Leukaemias. He also provides personalised cancer treatment.

Yes, Dr. P N Mohapatra is extensively involved in research and serves as a Principal Investigator for numerous international and national Phase III and Phase IV clinical trials.

Dr. P N Mohapatra specialises in the latest cancer treatments including Targeted Therapy, Immunotherapy, Hormone Therapy, advanced Chemotherapy regimens, and cutting-edge CAR T-Cell Therapy.